ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $213,096 | -64.4% | 10,400 | -65.5% | 0.00% | -60.0% |
| Q2 2023 | $598,563 | -40.1% | 30,124 | -41.0% | 0.01% | -37.5% |
| Q4 2022 | $998,540 | -14.9% | 51,024 | -30.6% | 0.01% | -20.0% |
| Q3 2022 | $1,174,000 | +30.0% | 73,512 | +77.6% | 0.01% | +25.0% |
| Q4 2021 | $903,000 | -57.6% | 41,400 | -41.9% | 0.01% | -63.6% |
| Q3 2021 | $2,130,000 | +32.9% | 71,270 | +96.9% | 0.02% | +29.4% |
| Q2 2021 | $1,603,000 | -1.0% | 36,203 | -0.8% | 0.02% | -15.0% |
| Q1 2021 | $1,619,000 | -25.5% | 36,501 | -7.9% | 0.02% | -31.0% |
| Q4 2020 | $2,173,000 | +265.2% | 39,612 | +52.2% | 0.03% | +163.6% |
| Q3 2020 | $595,000 | -72.1% | 26,021 | -74.5% | 0.01% | -62.1% |
| Q2 2020 | $2,132,000 | +157.2% | 101,910 | +179.7% | 0.03% | +45.0% |
| Q4 2019 | $829,000 | -5.9% | 36,435 | -51.8% | 0.02% | -23.1% |
| Q3 2019 | $881,000 | -67.9% | 75,600 | -58.7% | 0.03% | -73.2% |
| Q2 2019 | $2,744,000 | +535.2% | 182,900 | +643.5% | 0.10% | +546.7% |
| Q1 2019 | $432,000 | -71.5% | 24,600 | -75.9% | 0.02% | -74.1% |
| Q4 2018 | $1,514,000 | +145.8% | 102,200 | +308.8% | 0.06% | +114.8% |
| Q3 2018 | $616,000 | +34.2% | 25,000 | +2.2% | 0.03% | -20.6% |
| Q1 2018 | $459,000 | – | 24,460 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |